RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+25.68%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.77B
AUM Growth
+$6.77B
(+5.8%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
45.13%
Holding
79
New
15
Increased
25
Reduced
7
Closed
10
Top Buys
| 1 |
Stryker
SYK
|
$115M |
| 2 |
Immatics
IMTX
|
$89.5M |
| 3 |
Dyne Therapeutics
DYN
|
$87.8M |
| 4 |
Merus
MRUS
|
$78.2M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$72.8M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$398M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$314M |
| 3 |
Celldex Therapeutics
CLDX
|
$137M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$112M |
| 5 |
Vericel Corp
VCEL
|
$83.6M |
Sector Composition
| 1 | Healthcare | 99.98% |
| 2 | Financials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$143B
| – | – |
-118,584
| Closed | -$27.4M |
|
|
77
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-3,463,201
| Closed | -$137M |
|
78
Apyx Medical
APYX
$71.9M
| – | – |
-1,025,963
| Closed | -$2.69M |
|
|
79
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-1,640,559
| Closed | -$314M |
|